At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how evolving EU regulatory frameworks, including the Tobacco Products Directive (TPD3) and the Tobacco
At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how evolving EU taxation frameworks are shaping the regulation, availability, and market dynamics of
At EVO NXT 2026, the Global Institute for Novel Nicotine opened its programme with a panel session examining the latest scientific evidence, regulatory frameworks, and public health considerations surrounding tobacco
EVO NXT 2026 officially opened on April 17, 2026, at Forum Karlín in Prague, bringing together stakeholders from across the next-generation products (NGP) sector, including manufacturers, regulators, researchers, and public
Over the last decade, smoking has fallen across most high-income countries, but not at the same pace. In some jurisdictions, the decline has been steep; in others, more gradual and
The nicotine pouch category is evolving rapidly across global markets, driven by regulatory shifts, growing consumer adoption, and strategic investment from major industry players. At GINN, we are building an
Building on our initial look at the Commission’s TPD evaluation, the Tobacco Advertising Directive (TAD) is now being reframed to treat all nicotine products—traditional or novel—as part of a single
The Commission’s evaluation of the Tobacco Products Directive (TPD) 🎯 substantially overstates its public‑health success and fails to provide a credible evidence base for risk‑proportionate regulation of low‑risk nicotine products.
Comparative public health outcomes across countries can provide valuable insight into how regulatory frameworks shape behaviour, risk exposure, and long-term disease burden. A recent comparative analysis of Brazil and New
Ireland’s upcoming Presidency of the Council of the European Union presents a strategic opportunity to shape Europe’s public health agenda at a time of growing pressure on health systems and
New U.S. evidence highlights patterns relevant to harm reduction policy As nicotine pouches (ONPs) continue to expand in the United States, understanding how adult smokers engage with these products is
A productive and timely discussion in Vilnius with a European Parliament delegation led by Auke Zijlstra, MEP & Sebastian Kruis, MEP, Wilson George Group, NOIS Nicotine Pouches, Johan Nissinen, Glick®,